Biotech Archives -

News/ News/ Press Releases/ R&D/ Views and analysis

Touring Chiesi’s vision for the future at the new Biotech Centre of Excellence

Nicole Raleigh Alberto Chiesi, Antonio Magnelli, biologics, Biotech, Biotech Centre of Excellence, Chiesi, Chiesi Group, Francesca Usberti, Italy, Marcello Catani, Michele Guerra, monoclonal antibodies, Parma, pharma, R&D, Rare diseases, Stefano Bonaccini, Valentino Valentini, Vincenzo Colla 0 Comment

Following an invite to fly into Parma, Italy to witness first-hand the press launch of the considerable structure

Touring Chiesi’s vision for the future at the new Biotech Centre of Excellence

https://pharmaphorum.com/views-and-analysis/touring-chiesis-vision-for-the-future-at-the-new-biotech-centre-of-excellence/

Digital/ LSX Investech/ News/ Views and analysis

LSX Inv€$tival Showcase round-up

Eloise McLennan Biotech, digital, European, healthcare, healthtech, investment, Life Sciences, london, LSX, LSX Investival Showcase, medtech, startup 0 Comment

On 14th November, investors and life science & healthcare executives descended on London’s famed Old Billingsgate building to

LSX Inv€$tival Showcase round-up

https://pharmaphorum.com/views-and-analysis/lsx-invetival-showcase-round-up/

News/ News/ R&D

Stanford prof pays investors in defunct biotech Nuredis $29m

Phil Taylor Biotech, Huntington's disease, investment, litigation, Nuredis 0 Comment

A prominent genetics professor at Stanford University in the US has paid $29 million to investors in Nuredis

Stanford prof pays investors in defunct biotech Nuredis $29m

https://pharmaphorum.com/news/stanford-prof-pays-investors-in-defunct-biotech-nuredis-29m/

Patients/ Podcast/ R&D/ Video

A new hope in cachexia and an outsider’s view on pharma: the pharmaphorum podcast

Jonah Comstock Biotech, cachexia, cancer comorbidity, Endevica Pharma, Russell Potterfield 0 Comment

In the latest instalment of the pharmaphorum podcast, Editor in Chief Jonah Comstock sits down with Russell Potterfield,

A new hope in cachexia and an outsider’s view on pharma: the pharmaphorum podcast

https://pharmaphorum.com/patients/a-new-hope-in-cachexia/

News/ News/ R&D

Regeneron’s Inmazeb named Galien’s Best Biotech Product

Nicole Raleigh antibody therapeutics, Biotech, Ebola virus, FDA approval, Inmazeb, monoclonal antibodies, pharma, Prix Galien, Regeneron, The Galien Foundation 0 Comment

The Galien Foundation, which acknowledges “extraordinary scientific innovations that improve the human condition”, has awarded its Best Biotechnology

Regeneron’s Inmazeb named Galien’s Best Biotech Product

https://pharmaphorum.com/news/regenerons-inmazeb-named-galiens-best-biotech-product/

Close-up image of a firm handshake between two colleagues

News/ News/ Sales and Marketing

Neurocrine Bio agrees $57m takeover of UK biotech Diurnal

Phil Taylor Biotech, Diurnal, endocrinology, M&A, Neurocrine Biosciences 0 Comment

Neurocrine Biosciences has featured on lists of potential takeover candidates for years, but has now taken the lead

Neurocrine Bio agrees $57m takeover of UK biotech Diurnal

https://pharmaphorum.com/news/neurocrine-bio-agrees-57m-takeover-of-uk-biotech-diurnal/

News/ News/ R&D

Mereo fights revolt by largest shareholder Rubric

Phil Taylor Biotech, Financial, investors, Mereo, UK 0 Comment

UK biotech Mereo BioPharma is attempting to face down a revolt by Rubric Capital Management – its largest

Mereo fights revolt by largest shareholder Rubric

https://pharmaphorum.com/news/mereo-fights-revolt-by-largest-shareholder-rubric/

Closed up of sandglass or hourglass on background of book

Patients/ Views & Analysis/ Views and analysis

Long COVID but short on treatment options

Ben Hargreaves BioNTech, Biotech, COVID-19, Long COVID, Pfizer 0 Comment

With COVID-19 vaccines and therapeutics developed in rapid time, Ben Hargreaves investigates why this has not been the

Long COVID but short on treatment options

https://pharmaphorum.com/views-and-analysis/long-covid-but-short-on-treatment-options/

Digital/ Partner content/ Press releases

Respiratory Monitoring & AI Technologies

Nikisha Galoria biosensors, Biotech, digital health, medical devices, medical wearables 0 Comment

Returning for the 2nd annual year, the Biosensors for Medical Wearables Conference will be held in October 24

Respiratory Monitoring & AI Technologies

https://pharmaphorum.com/partner-content/respiratory-monitoring-ai-technologies/

Trending

Biotech

Login